Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review

Function and Activation of NF-kappaB in the Immune System

Baeuerle, P. A., & Henkel, T. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.001041 · Cited by 4,745

A Meta-Analysis of Cytokines in Major Depression

Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., & Lanctôt, K. L. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.033 · Cited by 4,729

The well-built clinical question: A key to evidence-based decisions

(1995) · ACP Journal Club · doi:10.7326/acpjc-1995-123-3-a12 · Cited by 2,931

Model of autism: increased ratio of excitation/inhibition in key neural systems

Rubenstein, J. L. R., & Merzenich, M. M. (2003) · Genes, Brain and Behavior · doi:10.1034/j.1601-183x.2003.00037.x · Cited by 2,768

Excitatory Amino Acids as a Final Common Pathway for Neurologic Disorders

Epstein, F. H., Lipton, S. A., & Rosenberg, P. A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403033300907 · Cited by 2,676

Drug Addiction and Its Underlying Neurobiological Basis: Neuroimaging Evidence for the Involvement of the Frontal Cortex

Goldstein, R. Z., & Volkow, N. D. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.10.1642 · Cited by 2,667

NEURAL MECHANISMS OF ADDICTION: The Role of Reward-Related Learning and Memory

Hyman, S. E., Malenka, R. C., & Nestler, E. J. (2006) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.29.051605.113009 · Cited by 2,647

Oxidative stress and mitochondrial dysfunction in Alzheimer’s disease

Wang, X., Wang, W., Li, L., Perry, G., Lee, H.-G., & Zhu, X. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.10.015 · Cited by 1,357

Glutathione, oxidative stress and neurodegeneration

Schulz, J. B., Lindenau, J. H., Seyfried, J., & DICHGANS, J. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01595.x · Cited by 1,225

Metaplasticity: tuning synapses and networks for plasticity

Abraham, W. C. (2008) · Nature reviews. Neuroscience · doi:10.1038/nrn2356 · Cited by 1,166

A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness

Maes, M., Galecki, P., Chang, Y. S., & Berk, M. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.05.004 · Cited by 1,140

Association of Dopamine Transporter Reduction With Psychomotor Impairment in Methamphetamine Abusers

Volkow, N. D., Chang, L. L., Wang, G., Fowler, J. S., Leonido–Yee, M., Franceschi, D., Sedler, M. J., Gatley, S. J., HITZEMANN, R. J., Ding, Y. ‐., et al. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.3.377 · Cited by 984

Mechanism of Oxidative Stress in Neurodegeneration

Gandhi, S., & Abramov, A. Y. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/428010 · Cited by 964

Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism

James, S. J., Cutler, P., Melnyk, S., Jernigan, S., Janak, L., Gaylor, D. W., & Neubrander, J. A. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.6.1611 · Cited by 955

Low Level of Brain Dopamine D2 Receptors in Methamphetamine Abusers: Association With Metabolism in the Orbitofrontal Cortex

Volkow, N. D., Chang, L., Wang, G.-J., Fowler, J. S., Ding, Y.-S., Sedler, M., Logan, J., Franceschi, D., Gatley, J., Hitzemann, R., et al. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.12.2015 · Cited by 916

The circuitry mediating cocaine-induced reinstatement of drug-seeking behavior

McFarland, K., & Kalivas, P. W. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-21-08655.2001 · Cited by 905

Prefrontal Glutamate Release into the Core of the Nucleus Accumbens Mediates Cocaine-Induced Reinstatement of Drug-Seeking Behavior

McFarland, K., Lapish, C. C., & Kalivas, P. W. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-08-03531.2003 · Cited by 884

The chemistry and biological activities of N-acetylcysteine

Samuni, Y., Goldstein, S., Dean, O. M., & Berk, M. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.04.016 · Cited by 876

Loss of Dopamine Transporters in Methamphetamine Abusers Recovers with Protracted Abstinence

Volkow, N. D., Chang, L. L., Wang, G., Fowler, J. S., Franceschi, D., Sedler, M. J., Gatley, S. J., Miller, E. N., HITZEMANN, R. J., Ding, Y., et al. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-23-09414.2001 · Cited by 754

Neuroadaptations in cystine-glutamate exchange underlie cocaine relapse

Baker, D. L., McFarland, K., LAKE, R. W., Shen, H., Tang, X., Toda, S., & Kalivas, P. W. (2003) · Nature Neuroscience · doi:10.1038/nn1069 · Cited by 740

Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments

Bilici, M., Efe, H., Köroğlu, M. A., Uydu, H. A., Bekaroğlu, M., & Değer, O. (2001) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00199-3 · Cited by 718

Psychomotor stimulant addiction: a neural systems perspective

Everitt, B. J., & Wolf, M. E. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-09-03312.2002 · Cited by 700

Gliogenesis and Glial Pathology in Depression

Rajkowska, G., & Miguel-Hidalgo, J. J. (2007) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152707780619326 · Cited by 625

Repeated cocaine augments excitatory amino acid transmission in the nucleus accumbens only in rats having developed behavioral sensitization

Pierce, R. C., Bell, K., Duffy, P., & Kalivas, P. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-04-01550.1996 · Cited by 624

Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autism

James, S. J., Melnyk, S., Jernigan, S., Cleves, M. A., Halsted, C. H., Wong, D. H., Cutler, P., Bock, K., Boris, M., Bradstreet, J., et al. (2006) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30366 · Cited by 618

Glutathione Pathways in the Brain

Dringen, R., & Hirrlinger, J. (2003) · Biological Chemistry · doi:10.1515/bc.2003.059 · Cited by 597

Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders

Gawryluk, J. W., Wang, J.-F., Andreazza, A. C., Shao, L., & Young, L. T. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710000805 · Cited by 594

Synthesis of the Antioxidant Glutathione in Neurons: Supply by Astrocytes of CysGly as Precursor for Neuronal Glutathione

Dringen, R., Pfeiffer, B., & Hamprecht, B. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-02-00562.1999 · Cited by 589

The Origin and Neuronal Function ofIn VivoNonsynaptic Glutamate

Baker, D. L., Xi, Z., Shen, H., Swanson, C. J., & Kalivas, P. W. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-20-09134.2002 · Cited by 584

A review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures

Rossignol, D. A., & Frye, R. E. (2011) · Molecular Psychiatry · doi:10.1038/mp.2011.165 · Cited by 555

Glutamate Transmission in the Nucleus Accumbens Mediates Relapse in Cocaine Addiction

Cornish, J. L., & Kalivas, P. W. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-15-j0006.2000 · Cited by 553

N-Acetyl Cysteine as a Glutathione Precursor for Schizophrenia—A Double-Blind, Randomized, Placebo-Controlled Trial

Berk, M., Copolov, D., Dean, O., Lu, K., Jeavons, S., Schapkaitz, I., Anderson-Hunt, M., Judd, F., Katz, F., Katz, P., et al. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.03.004 · Cited by 552

Molecular Mechanisms of Glutamate Receptor-Mediated Excitotoxic Neuronal Cell Death

Sattler, R., & Tymianski, M. (2001) · Molecular Neurobiology · doi:10.1385/mn:24:1-3:107 · Cited by 537

Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment

Davidson, C., Gow, A. J., Lee, T. H., & Ellinwood, E. H. (2001) · Brain Research Reviews · doi:10.1016/s0165-0173(01)00054-6 · Cited by 518

Randomized Trial of Acetylcysteine in Idiopathic Pulmonary Fibrosis

The Idiopathic Pulmonary Fibrosis Clinical Research Network (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1401739 · Cited by 506

Molecular Evidence for Mitochondrial Dysfunction in Bipolar Disorder

Konradi, C. L., Eaton, M. E., MacDonald, M. L., Walsh, J. P., Benes, F. M., & Heckers, S. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.3.300 · Cited by 503

N-Acetyl Cysteine for Depressive Symptoms in Bipolar Disorder—A Double-Blind Randomized Placebo-Controlled Trial

Berk, M., Copolov, D. L., Dean, O., Lu, K., Jeavons, S., Schapkaitz, I., Anderson-Hunt, M., & Bush, A. I. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.04.022 · Cited by 500

N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action

Dean, O., Giorlando, F., & Berk, M. (2011) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.100057 · Cited by 494

In vivo antioxidant treatment suppresses nuclear factor-kappa B activation and neutrophilic lung inflammation

Blackwell, T. S., Blackwell, T., Holden, E. P., Christman, B. W., & Christman, J. W. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.4.1630 · Cited by 483

Evidence of oxidative damage and inflammation associated with low glutathione redox status in the autism brain

Rose, S., Melnyk, S., Pavliv, O., Bai, S., Nick, T. G., Frye, R. E., & James, S. J. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.61 · Cited by 480

The promise of N-acetylcysteine in neuropsychiatry

Berk, M., Malhi, G. S., Gray, L. J., & Dean, O. M. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.01.001 · Cited by 434

Evidence of linkage between the serotonin transporter and autistic disorder

Cook, E., Yeung-Courchesne, R., Lord, C., Cox, N. J., Yan, S., Lincoln, A. J., Haas, R., Courchesne, E., & LEVENTHAL, B. L. (1997) · Molecular Psychiatry · doi:10.1038/sj.mp.4000266 · Cited by 426

N-Acetylcysteine, a Glutamate Modulator, in the Treatment of Trichotillomania: A Double-blind, Placebo-Controlled Study

Grant, J. E., Odlaug, B. L., & Won Kim, S. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.60 · Cited by 424

N‐acetylcysteine (NAC) in neurological disorders: mechanisms of action and therapeutic opportunities

Shahripour, R. B., Harrigan, M. R., & Alexandrov, A. V. (2014) · Brain and Behavior · doi:10.1002/brb3.208 · Cited by 423

Free radicals, antioxidant defense systems, and schizophrenia

Wu, J. Q., Kosten, T. R., & Zhang, X. Y. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.02.015 · Cited by 420

N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: The final common pathway on the road to schizophrenia?

Kantrowitz, J. T., & Javitt, D. C. (2010) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2010.04.006 · Cited by 414

Cystine/Glutamate Exchange Regulates Metabotropic Glutamate Receptor Presynaptic Inhibition of Excitatory Transmission and Vulnerability to Cocaine Seeking

Moran, M., McFarland, K., Meléndez, R. I., Kalivas, P. W., & Seamans, J. K. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.1007-05.2005 · Cited by 412

Dopaminergic dysfunction in schizophrenia: Salience attribution revisited

Heinz, A., & Schlagenhauf, F. (2010) · Schizophrenia Bulletin · doi:10.1093/schbul/sbq031 · Cited by 412

Methamphetamine-Related Psychiatric Symptoms and Reduced Brain Dopamine Transporters Studied With PET

Sekine, Y., Iyo, M., Ouchi, Y., Matsunaga, T., Tsukada, H., Okada, H., Yoshikawa, E., Futatsubashi, M., Takei, N., & Mori, N. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.8.1206 · Cited by 408

N-Acetylcysteine reverses cocaine-induced metaplasticity

Moussawi, K., Pacchioni, A. M., Moran, M., Olive, M. F., Gass, J. T., Lavín, A., & Kalivas, P. W. (2009) · Nature Neuroscience · doi:10.1038/nn.2250 · Cited by 403

Dopamine dysregulation syndrome: implications for a dopamine hypothesis of bipolar disorder

Berk, M., Dodd, S., Kauer‐Sant’Anna, M., Malhi, G. S., Bourin, M., Kapczinski, F., & Norman, T. (2007) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2007.01058.x · Cited by 396

Anatomical Substrates for Glutamate‐Dopamine Interactions

Sesack, S. R., CARR, D. B., Omelchenko, N., & Pinto, A. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1300.066 · Cited by 372

Glutamatergic Dysfunction in OCD

Chakrabarty, K., Bhattacharyya, S., Christopher, R., & Khanna, S. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300733 · Cited by 344

The cystine/cysteine cycle: a redox cycle regulating susceptibility versus resistance to cell death

Banjac, A., Perisic, T., Sato, H., Seiler, A., Bannai, S., Weiss, N., Kölle, P., Tschoep, K., Issels, R. D., Daniel, P. T., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210796 · Cited by 324

The Role of Oxidative Stress in Alzheimer Disease

Markesbery, W. R. (1999) · Archives of Neurology · doi:10.1001/archneur.56.12.1449 · Cited by 312

Cocaine Administered into the Medial Prefrontal Cortex Reinstates Cocaine-Seeking Behavior by Increasing AMPA Receptor-Mediated Glutamate Transmission in the Nucleus Accumbens

Park, W.-K., Bari, A., Jey, A. R., Anderson, S. M., Spealman, R. D., Rowlett, J. K., & Pierce, R. C. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-07-02916.2002 · Cited by 310

N-Acetyl Cysteine, a Glutamate-Modulating Agent, in the Treatment of Pathological Gambling: A Pilot Study

Grant, J. E., Kim, S. W., & Odlaug, B. L. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.11.021 · Cited by 307

A Double-Blind Randomized Controlled Trial of N -Acetylcysteine in Cannabis-Dependent Adolescents

Gray, K. M., Carpenter, M. J., Baker, N. L., DeSantis, S. M., Kryway, E., Hartwell, K. J., McRae-Clark, A. L., & Brady, K. T. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12010055 · Cited by 306

Mitochondrial involvement in psychiatric disorders

Shao, L., Martin, M. V., Watson, S. J., Schatzberg, A. F., Akil, H., Myers, R., Jones, E. G., Bunney, W. E., & Vawter, M. P. (2008) · Annals of Medicine · doi:10.1080/07853890801923753 · Cited by 303

Serotonin and psychostimulant addiction: Focus on 5-HT1A-receptors

Müller, C. P., Carey, R. J., Huston, J. P., & Silva, M. A. D. S. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.01.001 · Cited by 302

Early Depressive Symptoms in Cancer Patients Receiving Interleukin 2 and/or Interferon Alfa-2b Therapy

Capuron, L., Ravaud, A., & Dantzer, R. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.10.2143 · Cited by 293

A randomized controlled pilot trial of oral N-acetylcysteine in children with autism

Hardan, A. Y., Fung, L. K., Libove, R. A., Obukhanych, T. V., Nair, S., Herzenberg, L. A., Frazier, T. W., & Tirouvanziam, R. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.01.014 · Cited by 293

Dissociable Effects of Antagonism of NMDA and AMPA/KA Receptors in the Nucleus Accumbens Core and Shell on Cocaine-seeking Behavior

Ciano, P. D. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00235-4 · Cited by 287

Speed kills: cellular and molecular bases of methamphetamine‐induced nerve terminal degeneration and neuronal apoptosis

Cadet, J. L., Jayanthi, S., & Deng, X. (2003) · The FASEB Journal · doi:10.1096/fj.03-0073rev · Cited by 286

Elevated levels of GluR1 in the midbrain: a trigger for sensitization to drugs of abuse?

Carlezon, W. A., & Nestler, E. J. (2002) · Trends in Neurosciences · doi:10.1016/s0166-2236(02)02289-0 · Cited by 281

Astrocytes Provide Cysteine to Neurons by Releasing Glutathione

Wang, X. F., & Cynader, M. S. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0741434.x · Cited by 281

Chronic pain, depression, and quality of life: correlations and predictive value of the SF-36.

Elliott, T. E., Renier, C., & Palcher, J. A. (2003) · Pain medicine (Malden, Mass.) · doi:10.1111/j.1526-4637.2003.03040.x · Cited by 281

N‐acetylcysteine replenishes glutathione in HIV infection

Rosa, S. C. D., Zaretsky, M. D., Dubs, J. G., Roederer, M., Anderson, M., Green, A., Mitra, D. K., Watanabe, N., Nakamura, H., Tjioe, I., et al. (2000) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2000.00736.x · Cited by 278

Involvement of the cystine transport system xc- in the macrophage-induced glutamate-dependent cytotoxicity to neurons.

Piani, D., & Fontana, A. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.7.3578 · Cited by 274

Role of Dopamine Receptors in ADHD: A Systematic Meta-analysis

Wu, J., Xiao, H., Sun, H., Zou, L., & Zhu, L.-Q. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8278-5 · Cited by 274

ARSENIC‐INDUCED OXIDATIVE STRESS AND ITS REVERSIBILITY FOLLOWING COMBINED ADMINISTRATION OF N‐ACETYLCYSTEINE AND MESO 2,3–DIMERCAPTOSUCCINIC ACID IN RATS

Flora, S. J. S. (1999) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.1999.03157.x · Cited by 273

Role of Dopamine Transporter in Methamphetamine-Induced Neurotoxicity: Evidence from Mice Lacking the Transporter

Fumagalli, F., Gainetdinov, R. R., Valenzano, K. J., & Caron, M. G. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-13-04861.1998 · Cited by 266

Activation of microglia by secreted amyloid precursor protein evokes release of glutamate by cystine exchange and attenuates synaptic function

Barger, S. W., & Basile, A. S. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00075.x · Cited by 264

The mononuclear phagocyte system and its cytokine inflammatory networks in schizophrenia and bipolar disorder.

Drexhage, R. C., Knijff, E. M., Padmos, R. C., Heul-Nieuwenhuijzen, L. V. D., Beumer, W., Versnel, M. A., & Drexhage, H. A. (2010) · Expert Review of Neurotherapeutics · doi:10.1586/ern.09.144 · Cited by 263

The Role of Cystine-Glutamate Exchange in Nicotine Dependence in Rats and Humans

Knackstedt, L. A., LaRowe, S., Mardikian, P., Malcolm, R., Upadhyaya, H., Hedden, S., Markou, A., & Kalivas, P. W. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.10.040 · Cited by 260

Skin Picking Disorder

Grant, J. E., Odlaug, B. L., Chamberlain, S. R., Keuthen, N. J., Löchner, C., & Stein, D. J. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12040508 · Cited by 251

Metabolic imbalance associated with methylation dysregulation and oxidative damage in children with autism

Melnyk, S., Fuchs, G. J., Schulz, E., Lopez, M., Kahler, S. G., Fussell, J. J., Bellando, J., Pavliv, O., Rose, S., Seidel, L., et al. (2012) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-011-1260-7 · Cited by 250

Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in different phases of bipolar disorder and in schizophrenia

Kunz, M., Gama, C. S., Andreazza, A. C., Salvador, M. M., Ceresér, K. M., Gomes, F. A., Belmonte-de-Abreu, P. S., Berk, M., & Kapczinski, F. P. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.07.001 · Cited by 245

Baseline mood and psychosocial characteristics of patients developing depressive symptoms during interleukin-2 and/or interferon-alpha cancer therapy

Capuron, L., Ravaud, A., Miller, A. H., & Dantzer, R. (2003) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2003.11.004 · Cited by 243

Association of Dopamine Transporter Loss in the Orbitofrontal and Dorsolateral Prefrontal Cortices With Methamphetamine-Related Psychiatric Symptoms

Sekine, Y., Minabe, Y., Ouchi, Y., Takei, N., Iyo, M., Nakamura, K., Suzuki, K., Tsukada, H., Okada, H., Yoshikawa, E., et al. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.9.1699 · Cited by 242

Administration of N‐acetylcysteine after focal cerebral ischemia protects brain and reduces inflammation in a rat model of experimental stroke

Khan, M., Sekhon, B., Jatana, M., Giri, S., Gilg, A. G., Sekhon, C., Singh, I., & Singh, A. K. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20087 · Cited by 241

Controlled trial of N-acetylcysteine for patients with probable Alzheimer’s disease

Adair, J. C., Knoefel, J. E., & Morgan, N. (2001) · Neurology · doi:10.1212/wnl.57.8.1515 · Cited by 240

Abnormal neuronal differentiation and mitochondrial dysfunction in hair follicle-derived induced pluripotent stem cells of schizophrenia patients

Robicsek, O., Karry, R., Petit, I., Kesner, N. S., Müller, F.-J., Klein, E., Aberdam, D., & Ben‐Shachar, D. (2013) · Molecular Psychiatry · doi:10.1038/mp.2013.67 · Cited by 232

Repeated N-Acetylcysteine Administration Alters Plasticity-Dependent Effects of Cocaine

Madayag, A., Lobner, D., Kau, K. S., Mantsch, J. R., Abdulhameed, O., Hearing, M., Grier, M. D., & Baker, D. A. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2808-07.2007 · Cited by 225

Cellular and mitochondrial glutathione redox imbalance in lymphoblastoid cells derived from children with autism

James, S. J., Rose, S., Melnyk, S., Jernigan, S., Blossom, S. J., Pavliv, O., & Gaylor, D. W. (2009) · The FASEB Journal · doi:10.1096/fj.08-128926 · Cited by 223

Mitochondrial damage and dysfunction in traumatic brain injury.

Lifshitz, J., Sullivan, P., Hovda, D., Wieloch, T., & McIntosh, T. (2004) · Mitochondrion (Amsterdam. Print) · doi:10.1016/j.mito.2004.07.021 · Cited by 220

Is Cocaine Desire Reduced by N -Acetylcysteine?

LaRowe, S. D., Myrick, H., Hedden, S. L., Mardikian, P. N., Saladin, M. E., McRae‐Clark, A. L., Brady, K. T., Kalivas, P. W., & Malcolm, R. J. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.7.1115 · Cited by 217

N-acetylcysteine Boosts Brain and Blood Glutathione in Gaucher and Parkinson Diseases

Holmay, M. J., Terpstra, M., Coles, L. D., Mishra, U., Ahlskog, M., Öz, G., Cloyd, J. C., & Tuite, P. J. (2013) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e31829ae713 · Cited by 216

N-acetylcysteine and neurodegenerative diseases: Basic and clinical pharmacology

Arakawa, M., & Ito, Y. (2007) · The Cerebellum · doi:10.1080/14734220601142878 · Cited by 208

Amelioration of Acute Sequelae of Blast Induced Mild Traumatic Brain Injury by N-Acetyl Cysteine: A Double-Blind, Placebo Controlled Study

Hoffer, M. E., Balaban, C., Slade, M. D., Tsao, J. W., & Hoffer, B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054163 · Cited by 207

Preclinical and Clinical Evidence of Antioxidant Effects of Antidepressant Agents: Implications for the Pathophysiology of Major Depressive Disorder

Behr, G. A., Moreira, J. C. F., & Frey, B. N. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/609421 · Cited by 205

N-acetyl-l-cysteine (NAC) inhibits virus replication and expression of pro-inflammatory molecules in A549 cells infected with highly pathogenic H5N1 influenza A virus

Geiler, J., Michaelis, M., Naczk, P., Leutz, A., Langer, K., Doerr, H.-W., & Cinatl, J. J. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.08.025 · Cited by 205

Association between immune activation and early depressive symptoms in cancer patients treated with interleukin-2-based therapy

Capuron, L., Ravaud, A., Gualde, N., Bosmans, E., Dantzer, R., Maes, M., & Neveu, P. J. (2001) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(01)00030-0 · Cited by 201

N-acetylcysteine augmentation in serotonin reuptake inhibitor refractory obsessive-compulsive disorder

Lafleur, D. L., Pittenger, C., Kelmendi, B., Gardner, T., Wasylink, S., Malison, R. T., Sanacora, G., Krystal, J. H., & Coric, V. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0246-6 · Cited by 200

3-Nitrotyrosine and glutathione antioxidant system in patients in the early and late stages of bipolar disorder

Andreazza, A. C., Kapczinski, F. P., Kauer‐Sant’Anna, M., Walz, J. C., Bond, D. J., Gonçalves, C. A., Young, L. T., & Yatham, L. N. (2009) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0935 · Cited by 199

The role of dopamine oxidation in mitochondrial dysfunction: implications for Parkinson’s disease

Hastings, T. G. (2009) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-009-9257-z · Cited by 199

A Noradrenergic and Serotonergic Hypothesis of the Linkage Between Epilepsy and Affective Disorders

Jobe, P. C., Dailey, J. W., & Wernicke, J. F. (1999) · Critical Reviews in Neurobiology · doi:10.1615/critrevneurobiol.v13.i4.10 · Cited by 193

Temporal Characterization of Mitochondrial Bioenergetics after Spinal Cord Injury

Sullivan, P. G., Krishnamurthy, S., Patel, S. P., et al. (2007) · Journal of Neurotrauma · doi:10.1089/neu.2006.0242 · Cited by 191

Randomized, Double-Blind, Controlled Trial of Acetylcysteine in Amyotrophic Lateral Sclerosis

Louwerse, E. S., Weverling, G. J., Bossuyt, P. M., Meyjes, F. E. P., & de Jong, J. M. B. V. (1995) · Archives of Neurology · doi:10.1001/archneur.1995.00540300031009 · Cited by 186

The efficacy of N-acetylcysteine as an adjunctive treatment in bipolar depression: An open label trial

Berk, M., Dean, O., Cotton, S. M., Gama, C. S., Kapczinski, F., Fernandes, B. S., Kohlmann, K., Jeavons, S., Hewitt, K., Allwang, C., et al. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.06.005 · Cited by 181

Safety and Tolerability of N‐Acetylcysteine in Cocaine‐Dependent Individuals

LaRowe, S. D., Mardikian, P. N., Malcolm, R. J., Myrick, H., Kalivas, P. W., McFarland, K., Saladin, M. E., McRae‐Clark, A. L., & Brady, K. T. (2006) · American Journal on Addictions · doi:10.1080/10550490500419169 · Cited by 181

Repeated N-acetyl cysteine Reduces Cocaine Seeking in Rodents and Craving in Cocaine-Dependent Humans

Amen, S. L., Piacentine, L., Ahmad, M. E., Li, S.-J., Mantsch, J. R., Risinger, R., & Baker, D. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.226 · Cited by 179

An open-label trial of N-acetylcysteine for the treatment of cocaine dependence: A pilot study

Mardikian, P. N., LaRowe, S. D., Hedden, S., Kalivas, P. W., & Malcolm, R. J. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.10.001 · Cited by 179

Role of metabotropic glutamate receptors in oligodendrocyte excitotoxicity and oxidative stress

Deng, W., Wang, H., Rosenberg, P. A., Volpe, J. J., & Jensen, F. E. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307850101 · Cited by 179

The Efficacy of Adjunctive N-Acetylcysteine in Major Depressive Disorder: A Double-Blind, Randomized, Placebo-Controlled Trial

Berk, M., Dean, O. M., Cotton, S. M., Jeavons, S., Tanious, M., Kohlmann, K., Hewitt, K., Moss, K., Allwang, C., Schapkaitz, I., et al. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13m08454 · Cited by 172

N-Acetylcysteine in the Treatment of Pediatric Trichotillomania: A Randomized, Double-Blind, Placebo-Controlled Add-On Trial

Bloch, M., Panza, K. E., Grant, J., Pittenger, C., & Leckman, J. (2013) · Journal of the American Academy of Child and Adolescent Psychiatry · doi:10.1016/j.jaac.2012.12.020 · Cited by 171

Inhibitory Effect on Cerebral Inflammatory Response following Traumatic Brain Injury in Rats: A Potential Neuroprotective Mechanism of N‐Acetylcysteine

Chen, G., Shi, J., Hu, Z., & Hang, C. (2008) · Mediators of Inflammation · doi:10.1155/2008/716458 · Cited by 170

Cerebral cystine uptake: a tale of two transporters

McBean, G. J. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)02060-6 · Cited by 168

Alterations in behaviour and glutamate transmission following presentation of stimuli previously associated with cocaine exposure

Hotsenpiller, G., Giorgetti, M., & Wolf, M. E. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01804.x · Cited by 165

S-Nitrosothiols signal hypoxia-mimetic vascular pathology

Palmer, L. A., Doctor, A., Chhabra, P., Sheram, M. L., Laubach, V. E., Karlinsey, M. Z., Forbes, M. S., Macdonald, T. L., & Gaston, B. M. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29444 · Cited by 161

A randomized double blind placebo controlled clinical trial of N-Acetylcysteine added to risperidone for treating autistic disorders

Ghanizadeh, A. J., & Sarani, E. M. (2013) · BMC Psychiatry · doi:10.1186/1471-244x-13-196 · Cited by 158

N-Acetylcysteine as an Adjunct to Risperidone for Treatment of Negative Symptoms in Patients With Chronic Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Study

Farokhnia, M., Azarkolah, A., Adinehfar, F., Khodaie-Ardakani, M.-R., Hosseini, S.-M.-R., Yekehtaz, H., Tabrizi, M., Rezaei, F., Salehi, B., Sadeghi, S.-M.-H., et al. (2013) · Clinical Neuropharmacology · doi:10.1097/wnf.0000000000000001 · Cited by 155

A Double-Blind Placebo-Controlled Trial of N-Acetylcysteine in the Treatment of Cocaine Dependence

Larowe, S., Kalivas, P., Nicholas, J. S., Randall, P., Mardikian, P., & Malcolm, R. (2013) · American Journal on Addictions · doi:10.1111/j.1521-0391.2013.12034.x · Cited by 154

Motor Neuron Disease (Amyotrophic Lateral Sclerosis)

WILLIAMS, D. B., & Windebank, A. J. (1991) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)61175-6 · Cited by 154

The Psychiatric Manifestations of Mitochondrial Disorders: A Case and Review of the Literature

Anglin, R. E., Garside, S. L., Tarnopolsky, M. A., Mazurek, M. F., & Rosebush, P. I. (2012) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.11r07237 · Cited by 150

N-Acetylcysteine Normalizes Glutamate Levels in Cocaine-Dependent Patients: A Randomized Crossover Magnetic Resonance Spectroscopy Study

Schmaal, L., Veltman, D. J., Nederveen, A. J., van den Brink, W., & Goudriaan, A. E. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.66 · Cited by 147

Anti-inflammatory properties of N-acetylcysteine on lipopolysaccharide-activated macrophages

Palacio, J. R., Markert, U. R., & Martínez, P. (2011) · Inflammation Research · doi:10.1007/s00011-011-0323-8 · Cited by 145

The Effect of N-Acetylcysteine in the Nucleus Accumbens on Neurotransmission and Relapse to Cocaine

Kupchik, Y. M., Moussawi, K., Tang, X., Wang, X., Kalivas, B. C., Kolokithas, R., Ogburn, K. B., & Kalivas, P. W. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.10.024 · Cited by 145

Cystine/glutamate exchange serves as the source for extracellular glutamate: Modifications by repeated cocaine administration

Baker, D. L., Shen, H., & Kalivas, P. W. (2002) · Amino Acids · doi:10.1007/s00726-001-0122-6 · Cited by 140

Effect of antioxidant N-acetyl-l-cysteine on behavioral changes and neurotoxicity in rats after administration of methamphetamine

Fukami, G., Hashimoto, K., Koike, K., Okamura, N., Shimizu, E., & Iyo, M. (2004) · Brain Research · doi:10.1016/j.brainres.2004.04.072 · Cited by 137

Visualising the activity of the cystine‐glutamate antiporter in glial cells using antibodies to aminoadipic acid, a selectively transported substrate

Pow, D. V. (2001) · Glia · doi:10.1002/glia.1037 · Cited by 137

N-acetylcysteine add-on treatment in refractory obsessive-compulsive disorder: a randomized, double-blind, placebo-controlled trial.

Afshar, H., Roohafza, H., Mohammad-Beigi, H., Haghighi, M., Jahangard, L., Shokouh, P., Sadeghi, M., & Hafezian, H. (2012) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318272677d · Cited by 136

A Randomized, Placebo-Controlled Trial ofN-Acetylcysteine Plus Imaginal Desensitization for Nicotine-Dependent Pathological Gamblers

Grant, J. E., Odlaug, B. L., Chamberlain, S. R., Potenza, M. N., Schreiber, L. R. N., Donahue, C. B., & Kim, S. W. (2013) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13m08411 · Cited by 135

Oral and Intravenous Acetylcysteine for Treatment of Acetaminophen Toxicity: A Systematic Review and Meta-analysis

Green, J., Heard, K., Reynolds, K., & Albert, D. (2013) · Western Journal of Emergency Medicine · doi:10.5811/westjem.2012.4.6885 · Cited by 135

Erythrocyte Superoxide Dismutase and Glutathione Peroxidase Activities, and Malondialdehyde and Reduced Glutathione Levels in Schizophrenic Patients

Altuntaş, İ., Aksoy, H., Coşkun, İ., Çayköylü, A., & Akçay, F. (2000) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2000.201 · Cited by 131

Efficacy of a Vitamin/Nutriceutical Formulation for Moderate-stage to Later-stage Alzheimer's disease: A Placebo-controlled Pilot Study

Remington, R., Chan, A., Paskavitz, J., & Shea, T. B. (2008) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317508325094 · Cited by 129

The Dynamic Brain: Neuroplasticity and Mental Health

Kays, J. L., Hurley, R. A., & Taber, K. H. (2012) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/appi.neuropsych.12050109 · Cited by 128

Combination of Systemic Hypothermia and N-acetylcysteine Attenuates Hypoxic-Ischemic Brain Injury in Neonatal Rats

Jatana, M., Singh, I., Singh, A. K., & Jenkins, D. (2006) · Pediatric Research · doi:10.1203/01.pdr.0000215045.91122.44 · Cited by 126

N-Acetylcysteine as an Adjunctive Therapy to Risperidone for Treatment of Irritability in Autism

Nikoo, M., Radnia, H., Farokhnia, M., Mohammadi, M.-R., & Akhondzadeh, S. (2015) · Clinical Neuropharmacology · doi:10.1097/wnf.0000000000000063 · Cited by 122

Thinking Glutamatergically: Changing Concepts of Schizophrenia Based Upon Changing Neurochemical Models

Kantrowitz, J. T., & Javitt, D. C. (2010) · Clinical Schizophrenia & Related Psychoses · doi:10.3371/csrp.4.3.6 · Cited by 120

The role for N-acetylcysteine in the management of COPD

Dekhuijzen, P., & van Beurden, W. (2006) · International Journal of COPD · doi:10.2147/copd.2006.1.2.99 · Cited by 119

Role of serotonin in obsessive-compulsive disorder

Baumgarten, H. G., & Grozdanovic, Z. (1998) · The British Journal of Psychiatry · doi:10.1192/s0007125000297857 · Cited by 116

Chronic N-Acetylcysteine during Abstinence or Extinction after Cocaine Self-Administration Produces Enduring Reductions in Drug Seeking

Reichel, C. M., Moussawi, K., Do, P. H., Kalivas, P. W., & See, R. E. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.179317 · Cited by 116

Comparison of the 20-Hour Intravenous and 72-Hour Oral Acetylcysteine Protocols for the Treatment of Acute Acetaminophen Poisoning

Yarema, M. C., Johnson, D. W., Berlin, R. J., Sivilotti, M. L. A., Nettel‐Aguirre, A., Brant, R., Spyker, D. A., Bailey, B., Chalut, D. S., Lee, J. S., et al. (2009) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2009.05.010 · Cited by 114

Blunted cystine–glutamate antiporter function in the nucleus accumbens promotes cocaine-induced drug seeking

Kau, K. S., Madayag, A., Mantsch, J. R., Grier, M. D., Abdulhameed, O., & Baker, D. L. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.06.010 · Cited by 113

Contribution of Cystine–Glutamate Antiporters to the Psychotomimetic Effects of Phencyclidine

Baker, D. L., Madayag, A., Kristiansen, L. V., Meador‐Woodruff, J. H., Haroutunian, V. H., & Raju, I. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301532 · Cited by 113

N-acetylcysteine for major depressive episodes in bipolar disorder

Magalhães, P. V. D. S., Dean, O. M., Bush, A. I., Copolov, D., Malhi, G. S., Kohlmann, K., Jeavons, S., Schapkaitz, I., Anderson‐Hunt, M., & Berk, M. (2011) · Brazilian Journal of Psychiatry · doi:10.1590/s1516-44462011000400011 · Cited by 113

N-acetylcysteine has neuroprotective effects against oxaliplatin-based adjuvant chemotherapy in colon cancer patients: preliminary data

Lin, P., Lee, M.-Y., Wang, W.-S., et al. (2006) · Supportive Care in Cancer · doi:10.1007/s00520-006-0018-9 · Cited by 113

Superoxide dismutase and glutathione peroxidase function in progressive myoclonus epilepsies

Ben‐Menachem, E., Kyllerman, M., & Marklund, S. L. (2000) · Epilepsy Research · doi:10.1016/s0920-1211(00)00096-6 · Cited by 113

Effect of Oral N-Acetylcysteine Treatment on Plasma Inflammatory and Oxidative Stress Markers in Peritoneal Dialysis Patients: A Placebo-Controlled Study

do Nascimento, M. M., Suliman, M. E., Silva, M., Chinaglia, T., Marchioro, J. C., Hayashi, S. Y., RIELLA, M. C., Lindholm, B., & Anderstam, B. (2010) · Peritoneal Dialysis International · doi:10.3747/pdi.2009.00073 · Cited by 111

N‐Acetylcysteine (NAC) in Young Marijuana Users: An Open‐Label Pilot Study

Gray, K. M., Watson, N. L., Carpenter, M. J., & LaRowe, S. D. (2010) · The American Journal on Addictions · doi:10.1111/j.1521-0391.2009.00027.x · Cited by 109

Abnormal Transmethylation/transsulfuration Metabolism and DNA Hypomethylation Among Parents of Children with Autism

James, S. J., Melnyk, S., Jernigan, S., Hubanks, A., Rose, S., & Gaylor, D. W. (2008) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-008-0614-2 · Cited by 107

Brief Report: Attention Deficit and Hyperactivity Disorder Scores Are Elevated and Respond to N‐Acetylcysteine Treatment in Patients With Systemic Lupus Erythematosus

Garcia, R. J., Francis, L., Dawood, M., Lai, Z., Faraone, S. V., & Perl, A. (2013) · Arthritis & Rheumatism · doi:10.1002/art.37893 · Cited by 105

Amphetamine Depresses Excitatory Synaptic Transmission via Serotonin Receptors in the Ventral Tegmental Area

Jones, S., & Kauer, J. A. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-22-09780.1999 · Cited by 102

N-acetyl cysteine add-on treatment for bipolar II disorder: a subgroup analysis of a randomized placebo-controlled trial

Magalhães, P. V. D. S., Dean, O. M., Bush, A. I., Copolov, D., Malhi, G. S., Kohlmann, K., Jeavons, S., Schapkaitz, I., Anderson‐Hunt, M., & Berk, M. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.08.001 · Cited by 100

Cocaine Sensitization and Craving

Cornish, J. L., & Kalivas, P. W. (2001) · Journal of Addictive Diseases · doi:10.1300/j069v20n03_05 · Cited by 99

Efficacy and safety of N-acetylcysteine in prevention of noise induced hearing loss: A randomized clinical trial

Kopke, R. D., Slade, M. D., Jackson, R., et al. (2015) · Hearing Research · doi:10.1016/j.heares.2015.01.002 · Cited by 99

Alterations of Serotonin Transmission in Schizophrenia

Abi‐Dargham, A. (2007) · International review of neurobiology · doi:10.1016/s0074-7742(06)78005-9 · Cited by 98

Accelerated Aging in Schizophrenia Patients: The Potential Role of Oxidative Stress

Okusaga, O. O. (2014) · Aging and Disease · doi:10.14336/ad.2014.0500256 · Cited by 98

Maintenance N-acetyl cysteine treatment for bipolar disorder: A double-blind randomized placebo controlled trial

Berk, M., Dean, O. M., Cotton, S., Gama, C. S., Kapczinski, F. P., Fernandes, B. S., Kohlmann, K., Jeavons, S., Hewitt, K., Moss, K., et al. (2012) · BMC Medicine · doi:10.1186/1741-7015-10-91 · Cited by 96

Abnormal Transmethylation/transsulfuration Metabolism and DNA Hypomethylation Among Parents of Children with Autism

James, S. J., Melnyk, S., Jernigan, S., Hubanks, A., Rose, S., & Gaylor, D. W. (2008) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-008-0591-5 · Cited by 96

N-Acetyl Cysteine in the Treatment of Grooming Disorders

Odlaug, B. L., & Grant, J. E. (2007) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000264976.86990.00 · Cited by 94

A double-blind, placebo-controlled study of N-acetyl cysteine plus naltrexone for methamphetamine dependence.

Grant, J., Odlaug, B., & Kim, S.-W. (2010) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2010.06.018 · Cited by 93

Intracellular and Extracellular Redox Status and Free Radical Generation in Primary Immune Cells from Children with Autism

Rose, S., Melnyk, S., Trusty, T. A., Pavliv, O., Seidel, L., Li, J., Nick, T. G., & James, S. J. (2011) · Autism Research and Treatment · doi:10.1155/2012/986519 · Cited by 93

Efficacy of N-Acetylcysteine in the Treatment of Nicotine Dependence: A Double-Blind Placebo-Controlled Pilot Study

Schmaal, L., Berk, L., Hulstijn, K. P., Cousijn, J., Wiers, R. W., & van den Brink, W. (2011) · European Addiction Research · doi:10.1159/000327682 · Cited by 93

N-Acetylcysteine Reverses Mitochondrial Dysfunctions and Behavioral Abnormalities in 3-Nitropropionic Acid-Induced Huntington’s Disease

Sandhir, R., Sood, A., Mehrotra, A., & Kamboj, S. S. (2012) · Neurodegenerative Diseases · doi:10.1159/000334273 · Cited by 90

Does dopamine dysfunction drive depression?

Malhi, G. S., & Berk, M. (2007) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2007.00969.x · Cited by 86

N-acetylcysteine possesses antidepressant-like activity through reduction of oxidative stress: Behavioral and biochemical analyses in rats

Smaga, I., Pomierny, B., Krzyżanowska, W., Pomierny-Chamioło, L., Miszkiel, J., Niedzielska, E., Ogorka, A. Z. T., & Filip, M. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.06.018 · Cited by 86

Oxidative imbalance in obsessive compulsive disorder patients: A total evaluation of oxidant–antioxidant status

Selek, S., Herken, H., Bulut, M., Ceylan, M. F., Çelık, H., SAVAS, H. A., & Erel, Ö. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.10.002 · Cited by 85

N-acetylcysteine improves redox status, mitochondrial dysfunction, mucin-depleted crypts and epithelial hyperplasia in dextran sulfate sodium-induced oxidative colitis in mice

Amrouche-Mekkioui, I., & Djerdjouri, B. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.06.014 · Cited by 83

Activation of group I metabotropic glutamate receptors reduces neuronal apoptosis but increases necrotic cell death in vitro

Allen, J. W., Knoblach, S. M., & Faden, A. I. (2000) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400678 · Cited by 83

Treatment of four siblings with progressive myoclonus epilepsy of the Unverricht-Lundborg type with N-acetylcysteine

Hurd, R. W., Wilder, B. J., Helveston, W. R., & Uthman, B. M. (1996) · Neurology · doi:10.1212/wnl.47.5.1264 · Cited by 82

Glutathione Is an Endogenous Ligand of Rat Brain N-Methyl-D-Aspartate (NMDA) and 2-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionate (AMPA) Receptors

Varga, V., Jenei, Z., Janáky, R., Saransaari, P., & Oja, S. S. (1997) · Neurochemical Research · doi:10.1023/a:1027377605054 · Cited by 81

N-acetylcysteine Protects Mice from Lethal Endotoxemia by Regulating the Redox State of Immune Cells

Víctor, V. M., Rocha, M., & la Fuente, M. D. (2003) · Free Radical Research · doi:10.1080/1071576031000148727 · Cited by 78

The Psychiatric Presentation of Mitochondrial Disorders in Adults

Anglin, R. E., Tarnopolsky, M. A., Mazurek, M. F., & Rosebush, P. I. (2012) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/appi.neuropsych.11110345 · Cited by 77

Role of tumour necrosis factor and reactive oxygen intermediates in lipopolysaccharide-induced pulmonary oedema and lethality

Gatti, S., Faggioni, R., Echtenacher, B., et al. (1993) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1993.tb05924.x · Cited by 75

Beneficial effects of N-acetylcysteine in treatment resistant schizophrenia

Bulut, M., Savas, H. A., Altindag, A., Virit, O., & Dalkilic, A. (2009) · The World Journal of Biological Psychiatry · doi:10.1080/15622970903144004 · Cited by 73

An open‐label pilot study of N‐acetylcysteine for skin‐picking in Prader–Willi syndrome

Miller, J. L., & Angulo, M. (2014) · American Journal of Medical Genetics. Part A · doi:10.1002/ajmg.a.36306 · Cited by 70

System xc− regulates microglia and macrophage glutamate excitotoxicity in vivo

Kigerl, K. A., Ankeny, D. P., Garg, S. K., Wei, P. Y., Guan, Z., Lai, W., McTigue, D. M., Banerjee, R. V., & Popovich, P. G. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.10.025 · Cited by 70

The mitochondrial genome and psychiatric illness

Anglin, R., Mazurek, M. F., Tarnopolsky, M. A., & Rosebush, P. I. (2012) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32086 · Cited by 69

N-acetylcysteine for therapy-resistant tobacco use disorder: a pilot study

Prado, E., Maes, M., Piccoli, L. G., Baracat, M., Barbosa, D. S., Franco, O., Dodd, S., Berk, M., & Vargas Nunes, S. O. (2015) · Redox Report · doi:10.1179/1351000215y.0000000004 · Cited by 69

The efficacy of N-acetylcysteine in the treatment of methamphetamine dependence: a double-blind controlled, crossover study.

Mousavi, S. G., Sharbafchi, M. R., Salehi, M., Peykanpour, M., Sichani, N. K., & Maracy, M. R. (2015) · PubMed · Cited by 67

N-acetylcysteine in the Treatment of Trichotillomania

Rodrigues-Barata, A. R., Tosti, A., Rodriguez-Pichardo, A., & Camacho-Martínez, F. (2012) · International Journal of Trichology · doi:10.4103/0974-7753.100090 · Cited by 65

Effect of N-acetylcysteine treatment on oxidative stress and inflammation after severe burn

Csontos, C., Rezman, B., Földi, V., Bogár, L., Drenkovics, L., Roth, E. B., Wéber, G., & Lantos, J. (2011) · Burns · doi:10.1016/j.burns.2011.09.011 · Cited by 65

N-acetylcysteine Versus Placebo for Treating Nail Biting, a Double Blind Randomized Placebo Controlled Clinical Trial

Ghanizadeh, A. J., Derakhshan, N., & Berk, M. (2013) · Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry · doi:10.2174/1871523011312030003 · Cited by 64

Status epilepticus after a massive intravenous N-acetylcysteine overdose leading to intracranial hypertension and death

Bailey, B., Blais, R., & Letarte, A. (2004) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2004.05.014 · Cited by 64

Effects of N‐acetyl cysteine on cognitive function in bipolar disorder

Dean, O. M., Bush, A. I., Copolov, D. L., Kohlmann, K., Jeavons, S., Schapkaitz, I., Anderson‐Hunt, M., & Berk, M. (2012) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2012.02392.x · Cited by 58

Nail-Biting Stuff? The Effect of N-acetyl Cysteine on Nail-Biting

Berk, M., Jeavons, S., Dean, O. M., Dodd, S., Moss, K., Gama, C. S., & Malhi, G. S. (2009) · CNS Spectrums · doi:10.1017/s1092852900023002 · Cited by 58

A preliminary investigation on the efficacy of N -acetyl cysteine for mania or hypomania

Vieira da Silva Magalhães, P., Dean, O. M., Bush, A. I., Copolov, D. L., Malhi, G. S., Kohlmann, K., Jeavons, S., Schapkaitz, I., Anderson-Hunt, M., & Berk, M. (2013) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867413481631 · Cited by 58

Oxidized glutathione modulates and depolarization-induced increases in intracellular Ca2+ in cultured rat forebrain neurons

Gilbert, K. R., Aizenman, E., & Reynolds, I. J. (1991) · Neuroscience Letters · doi:10.1016/0304-3940(91)90045-u · Cited by 57

N -acetylcysteine and Unverricht–Lundborg disease Variable response and possible side effects

Edwards, M. J., Hargreaves, I., Heales, S., et al. (2002) · Neurology · doi:10.1212/wnl.59.9.1447 · Cited by 56

Alcoholism and alcohol abstinence: N-acetylcysteine to improve energy expenditure, myocardial oxidative stress, and energy metabolism in alcoholic heart disease

Seiva, F. R. F., Amauchi, J. F., Rocha, K. K. R., et al. (2009) · Alcohol · doi:10.1016/j.alcohol.2009.09.028 · Cited by 51

Survival in patients with amyotrophic lateral sclerosis, treated with an array of antioxidants

Vyth, A., Timmer, J. G., Bossuyt, P. M., Louwerse, E. S., & de Jong, J. M. B. V. (1996) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(96)00071-8 · Cited by 50

Stimulation of N-methyl-D-aspartate receptor-mediated calcium entry into dissociated neurons by reduced and oxidized glutathione.

Leslie, S. W., Brown, L. M., Trent, R. D., Lee, Y. H., Morris, J. L., Jones, T. W. A., Randall, P. K., Lau, S. S., & Monks, T. J. (1992) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08878-9 · Cited by 48

The Cystine/Cysteine Cycle and GSH Are Independent and Crucial Antioxidant Systems in Malignant Melanoma Cells and Represent Druggable Targets

Venè, R., Castellani, P., Delfino, L., Lucibello, M., Ciriolo, M. R., & Rubartelli, A. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3830 · Cited by 47

N-acetylcysteine for treatment of autism, a case report.

Ghanizadeh, A. J., & Derakhshan, N. (2012) · PubMed · Cited by 45

Impairment in Consolidation of Learned Place Preference Following Dopaminergic Neurotoxicity in Mice is Ameliorated by N-acetylcysteine but not D1 and D2 Dopamine Receptor Agonists

Achat‐Mendes, C., Anderson, K. L., & Itzhak, Y. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301119 · Cited by 45

Effect of hemorrhagic shock on gut barrier function and expression of stress-related genes in normal and gnotobiotic mice

Yang, R., Gallo, D. J., Baust, J., Watkins, S. C., Delude, R. L., & Fink, M. P. (2002) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00278.2002 · Cited by 45

Persistent inflammation and its relationship to leptin and insulin in phases of bipolar disorder from acute depression to full remission

Tsai, S., Chung, K., Huang, S., Chen, P., Lee, H., & Kuo, C. (2014) · Bipolar Disorders · doi:10.1111/bdi.12240 · Cited by 43

Effect of N ‐acetylcysteine on cardiac injury and oxidative stress after abdominal aortic aneurysm repair: A randomized controlled trial

Mahmoud, K. M., & Ammar, A. (2011) · Acta Anaesthesiologica Scandinavica · doi:10.1111/j.1399-6576.2011.02492.x · Cited by 40

Efficacy of N-acetylcysteine in preventing atrial fibrillation after cardiac surgery: a meta-analysis of published randomized controlled trials

Liu, X., Xu, C.-Y., & Fan, G.-H. (2014) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-14-52 · Cited by 37

Assessing oxidative pathway genes as risk factors for bipolar disorder

Fullerton, J. M., Tiwari, Y., Agahi, G., Heath, A., Berk, M., Mitchell, P. B., & Schofield, P. R. (2010) · Bipolar Disorders · doi:10.1111/j.1399-5618.2010.00834.x · Cited by 37

Marijuana craving trajectories in an adolescent marijuana cessation pharmacotherapy trial

Roten, A. T., Baker, N. L., & Gray, K. M. (2012) · Addictive Behaviors · doi:10.1016/j.addbeh.2012.11.003 · Cited by 35

Clinical features and genetics of progressive myoclonus epilepsy of the Unverricht-Lundborg type

Lehesjoki, A., & Koskiniemi, M. (1998) · Annals of Medicine · doi:10.3109/07853899809002489 · Cited by 34

An in vivo and in vitro study on the protective effects of N-acetylcysteine on mitochondrial dysfunction in isoproterenol treated myocardial infarcted rats

Basha, R. H., & Priscilla, D. H. (2011) · Experimental and Toxicologic Pathology · doi:10.1016/j.etp.2011.05.002 · Cited by 33

Qualitative Methods in Early-Phase Drug Trials

Berk, M., Munib, A., Dean, O. M., Malhi, G. S., Kohlmann, K., Schapkaitz, I., Jeavons, S., Katz, F., Anderson‐Hunt, M., Conus, P., et al. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09m05741yel · Cited by 33

N-acetylcysteine in the treatment of skin-picking disorder

Silva-Netto, R., de Jesus, G. N., Nogueira, M. S., & Tavares, H. (2014) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2013-1154 · Cited by 33

Cigarette smoking during an N -acetylcysteine-assisted cannabis cessation trial in adolescents

McClure, E. A., Baker, N. L., & Gray, K. M. (2014) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952990.2013.878718 · Cited by 33

Effects of α-phenyl-N-tert-butyl nitrone and N-acetylcysteine on hydroxyl radical formation and dopamine depletion in the rat striatum produced by d-amphetamine

Wan, F.-J., Tung, C., Shiah, I., et al. (2005) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2005.07.002 · Cited by 31

N-acetylcysteine amide, a thiol antioxidant, prevents bleomycin-induced toxicity in human alveolar basal epithelial cells (A549)

Tobwala, S., Fan, W., Stoeger, T., et al. (2013) · Free Radical Research · doi:10.3109/10715762.2013.819974 · Cited by 29

N-Acetylcysteine (NAC): Impacts on Human Health

Tenório, M. C. D. S., Graciliano, N. G., Moura, F. A., Oliveira, A. C. M. D., & Goulart, M. O. F. (2021) · Antioxidants · doi:10.3390/antiox10060967 · Cited by 526

Nutritional psychiatry: The present state of the evidence

Marx, W., Moseley, G., Berk, M., & Jacka, F. (2017) · Proceedings of the Nutrition Society · doi:10.1017/s0029665117002026 · Cited by 469

Cognitive remission: a novel objective for the treatment of major depression?

Bortolato, B., Miskowiak, K. W., Köhler, C. A., Maes, M., Fernandes, B. S., Berk, M., & Carvalho, A. F. (2016) · BMC Medicine · doi:10.1186/s12916-016-0560-3 · Cited by 252

Peripheral Markers of Depression

Nobis, A., Zalewski, D., & Waszkiewicz, N. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9123793 · Cited by 197

Amino acid catabolism in Alzheimer’s disease brain: Friend or foe?

Griffin, J. W. D., & Bradshaw, P. C. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/5472792 · Cited by 185

Riluzole

Bryson, H. M., Fulton, B., & Benfield, P. (1996) · Drugs · doi:10.2165/00003495-199652040-00010 · Cited by 220

Effects of riluzole on symptom progression in amyotrophic lateral sclerosis

Sojka, P. A., Andersen, P. M., & Forsgren, L. (1997) · The Lancet · doi:10.1016/s0140-6736(05)60977-4 · Cited by 22

Outcome of sporadic amyotrophic lateral sclerosis treated with non-invasive ventilation and riluzole.

Sívori, M., Rodriguez, G. E., Pascansky, D., et al. (2007) · PubMed · Cited by 14

Real-world evidence of riluzole effectiveness in treating amyotrophic lateral sclerosis

Andrews, J. A., Jackson, C. E., Heiman-Patterson, T. D., Bettica, P. U., Brooks, B. R., & Pioro, E. P. (2020) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2020.1771734 · Cited by 158

Riluzole for the Treatment of Amyotrophic Lateral Sclerosis

Saitoh, Y., & Takahashi, Y. (2020) · Neurodegenerative Disease Management · doi:10.2217/nmt-2020-0033 · Cited by 110